Table of Contents
Mutual Fund Calculator
What is Mutual Fund?
A mutual fund is a professionally managed investment scheme. It is run by an asset management company (AMC) which acts like a mediator for the retail investors. The AMC pools in money from a large number of investors and invests it in equity shares, Bonds, money market instruments and other types of securities. Buying a mutual fund is like buying a small slice of a big pizza. Each investor, in return, is assigned a specific number of units proportionate to his invested amount in the fund. The investor is known as the unit holder. The unit holder shares the gains, losses, income and expenses of the fund in proportion to his investment in the fund.
What is a Mutual Fund Calculator ?
Mutual Fund Calculator helps us in Calculating our interest return for SIP investments or lump sum investment with the help of Fincash Mutual Fund Calculator below.
How does a mutual fund calculator work?
Is your mutual fund scheme generating returns in line with your expectation? Are you wondering what amount of SIP would help you in personal goal accomplishment? Get your answers by using our Mutual Fund Calculator! The Mutual Fund Calculator will give you the investment value at maturity by calculating fund returns according to your investment horizon. You can adjust the variables of the calculator like SIP/lump sum, amount of investment, frequency of SIP, expected rate of return and duration of SIP
Nature of investment ( SIP / Lumpsum )
There are basically two ways of Investing money in your favourite Mutual Funds. You can go via the SIP or the lump sum route
1. Lump sum investment
Under a lump sum, you invest one big chunk of your funds in mutual fund scheme of your choice. It generally happens when you receive huge corpus from say sale of an asset or retirement benefits. But investing a lump sum involves greater risk. That’s why it is always recommended to go via the SIP route
2. Systematic Investment Plan (SIP)
Under a SIP, you instruct the bank to deduct a? the fixed sum from your Savings Account every month and invest it in the said mutual fund scheme. In this way, you can buy units continuously without worrying about the right time to enter the market. You get the benefit of rupee cost averaging and enjoy the Power of Compounding
Talk to our investment specialist
Types of Calculators
Lumpsum Calculator
SIP Calculator
Know Your SIP Returns
Top Funds for 2020
*Best funds based on 1 year performance.
(Erstwhile UTI Pharma & Healthcare Fund) The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors. UTI Healthcare Fund is a Equity - Sectoral fund was launched on 28 Jun 99. It is a fund with High risk and has given a Below is the key information for UTI Healthcare Fund Returns up to 1 year are on (Erstwhile SBI Pharma Fund) To provide the investors maximum growth opportunity through equity
investments in stocks of growth oriented sectors of the economy. SBI Healthcare Opportunities Fund is a Equity - Sectoral fund was launched on 31 Dec 04. It is a fund with High risk and has given a Below is the key information for SBI Healthcare Opportunities Fund Returns up to 1 year are on The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies. Nippon India Pharma Fund is a Equity - Sectoral fund was launched on 5 Jun 04. It is a fund with High risk and has given a Below is the key information for Nippon India Pharma Fund Returns up to 1 year are on 1. UTI Healthcare Fund
CAGR/Annualized return of 14.2% since its launch. Ranked 40 in Sectoral category. Return for 2019 was 1.2% , 2018 was -7.5% and 2017 was 6.2% . UTI Healthcare Fund
Growth Launch Date 28 Jun 99 NAV (19 Oct 20) ₹129.181 ↓ -1.19 (-0.91 %) Net Assets (Cr) ₹586 on 30 Sep 20 Category Equity - Sectoral AMC UTI Asset Management Company Ltd Rating ☆ Risk High Expense Ratio 2.77 Sharpe Ratio 1.79 Information Ratio 0.39 Alpha Ratio 7.99 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Sep 15 ₹10,000 30 Sep 16 ₹9,340 30 Sep 17 ₹8,224 30 Sep 18 ₹8,901 30 Sep 19 ₹7,799 30 Sep 20 ₹12,984 Returns for UTI Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 19 Oct 20 Duration Returns 1 Month -2.6% 3 Month 17.2% 6 Month 32.3% 1 Year 63.9% 3 Year 15% 5 Year 4.6% 10 Year 15 Year Since launch 14.2% Historical performance (Yearly) on absolute basis
Year Returns 2019 1.2% 2018 -7.5% 2017 6.2% 2016 -9.7% 2015 12.4% 2014 43.7% 2013 23.3% 2012 24.8% 2011 -9.6% 2010 37.4% Fund Manager information for UTI Healthcare Fund
Name Since Tenure V Srivatsa 3 Mar 17 3.58 Yr. Data below for UTI Healthcare Fund as on 30 Sep 20
Equity Sector Allocation
Sector Value Health Care 92.82% Basic Materials 2.76% Asset Allocation
Asset Class Value Cash 4.42% Equity 95.58% Top Securities Holdings / Portfolio
Name Holding Value Quantity Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | 50012411% ₹64 Cr 124,140
↓ -8,667 Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMA11% ₹62 Cr 1,239,120
↓ -50,672 Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB8% ₹45 Cr 148,420
↓ -29,385 Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | 5000877% ₹43 Cr 559,275
↑ 47,090 Ipca Laboratories Ltd (Healthcare)
Equity, Since 31 Jan 14 | 5244946% ₹36 Cr 164,427
↓ -24,102 Cadila Healthcare Ltd (Healthcare)
Equity, Since 31 Jan 03 | 5323216% ₹34 Cr 848,211
↑ 241,414 Aurobindo Pharma Ltd (Healthcare)
Equity, Since 31 Oct 13 | AUROPHARMA4% ₹25 Cr 309,240
↓ -21,904 Eris Lifesciences Ltd Registered Shs (Healthcare)
Equity, Since 31 Mar 19 | 5405964% ₹24 Cr 446,812
↓ -19,156 Biocon Ltd (Healthcare)
Equity, Since 31 Oct 18 | 5325234% ₹24 Cr 533,700
↓ -12,684 Laurus Labs Ltd (Healthcare)
Equity, Since 30 Apr 20 | 5402224% ₹23 Cr 786,180
↓ -365,340 2. SBI Healthcare Opportunities Fund
CAGR/Annualized return of 14.1% since its launch. Ranked 34 in Sectoral category. Return for 2019 was -0.5% , 2018 was -9.9% and 2017 was 2.1% . SBI Healthcare Opportunities Fund
Growth Launch Date 31 Dec 04 NAV (19 Oct 20) ₹178.376 ↓ -1.50 (-0.83 %) Net Assets (Cr) ₹1,434 on 30 Sep 20 Category Equity - Sectoral AMC SBI Funds Management Private Limited Rating ☆☆ Risk High Expense Ratio 2.44 Sharpe Ratio 1.81 Information Ratio -0.14 Alpha Ratio 8.46 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-15 Days (0.5%),15 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Sep 15 ₹10,000 30 Sep 16 ₹9,571 30 Sep 17 ₹8,069 30 Sep 18 ₹8,329 30 Sep 19 ₹7,208 30 Sep 20 ₹11,813 Returns for SBI Healthcare Opportunities Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 19 Oct 20 Duration Returns 1 Month -1.8% 3 Month 16.8% 6 Month 32.3% 1 Year 61.5% 3 Year 12.1% 5 Year 2.8% 10 Year 15 Year Since launch 14.1% Historical performance (Yearly) on absolute basis
Year Returns 2019 -0.5% 2018 -9.9% 2017 2.1% 2016 -14% 2015 27.1% 2014 56.8% 2013 26% 2012 37.1% 2011 -5.5% 2010 29.1% Fund Manager information for SBI Healthcare Opportunities Fund
Name Since Tenure Tanmaya Desai 1 Jun 11 9.34 Yr. Data below for SBI Healthcare Opportunities Fund as on 30 Sep 20
Equity Sector Allocation
Sector Value Health Care 97.22% Basic Materials 0.38% Asset Allocation
Asset Class Value Cash 2.4% Equity 97.6% Top Securities Holdings / Portfolio
Name Holding Value Quantity Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 20 | 50012411% ₹156 Cr 300,000
↑ 20,000 Lupin Ltd (Healthcare)
Equity, Since 31 Jul 18 | 50025710% ₹141 Cr 1,400,000 Cipla Ltd (Healthcare)
Equity, Since 31 Aug 16 | 50008710% ₹139 Cr 1,800,000 Aurobindo Pharma Ltd (Healthcare)
Equity, Since 30 Apr 20 | AUROPHARMA8% ₹119 Cr 1,500,000 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB8% ₹110 Cr 360,000
↑ 8,140 Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Dec 17 | SUNPHARMA7% ₹100 Cr 2,000,000
↓ -500,000 Strides Pharma Science Ltd (Healthcare)
Equity, Since 31 Mar 14 | STAR5% ₹65 Cr 900,000
↓ -100,000 Narayana Hrudayalaya Ltd (Healthcare)
Equity, Since 31 Dec 19 | NH4% ₹57 Cr 1,600,000 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Apr 20 | APOLLOHOSP3% ₹47 Cr 220,000 Sequent Scientific Ltd (Healthcare)
Equity, Since 31 Jul 14 | 5125293% ₹46 Cr 3,000,000 3. Nippon India Pharma Fund
CAGR/Annualized return of 21% since its launch. Ranked 35 in Sectoral category. Return for 2019 was 1.7% , 2018 was 3.6% and 2017 was 7.6% . Nippon India Pharma Fund
Growth Launch Date 5 Jun 04 NAV (19 Oct 20) ₹227.169 ↓ -2.62 (-1.14 %) Net Assets (Cr) ₹3,911 on 30 Sep 20 Category Equity - Sectoral AMC Nippon Life Asset Management Ltd. Rating ☆☆ Risk High Expense Ratio 2.33 Sharpe Ratio 1.67 Information Ratio 1.02 Alpha Ratio 4.83 Min Investment 5,000 Min SIP Investment 100 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Sep 15 ₹10,000 30 Sep 16 ₹9,404 30 Sep 17 ₹8,381 30 Sep 18 ₹10,297 30 Sep 19 ₹9,129 30 Sep 20 ₹14,672 Returns for Nippon India Pharma Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 19 Oct 20 Duration Returns 1 Month -2.8% 3 Month 14.8% 6 Month 28.8% 1 Year 59.4% 3 Year 19.5% 5 Year 7.8% 10 Year 15 Year Since launch 21% Historical performance (Yearly) on absolute basis
Year Returns 2019 1.7% 2018 3.6% 2017 7.6% 2016 -10.6% 2015 19.4% 2014 49.5% 2013 20.9% 2012 34.8% 2011 -11% 2010 31.9% Fund Manager information for Nippon India Pharma Fund
Name Since Tenure Sailesh Raj Bhan 1 Apr 05 15.51 Yr. Kinjal Desai 25 May 18 2.35 Yr. Data below for Nippon India Pharma Fund as on 30 Sep 20
Equity Sector Allocation
Sector Value Health Care 96.75% Asset Allocation
Asset Class Value Cash 3.25% Equity 96.75% Top Securities Holdings / Portfolio
Name Holding Value Quantity
All efforts have been made to ensure the information provided here is accurate. However, no guarantees are made regarding correctness of data. Please verify with scheme information document before making any investment.
AMFI Registration No. 112358 | CIN: U74999MH2016PTC282153
Shepard Technologies Pvt. Ltd. (with ARN code 112358) makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Terms and conditions of the website are applicable.
©2020 Shepard Technologies Private Limited. All Rights Reserved